Bioorthogonal Epigenetic Anchoring Of Heterochromatin To The Nuclear Lamina Reverses Senescence And Osteoarthritis
As we age, our bodies undergo various changes, and one significant factor contributing to age-related diseases like osteoarthritis is the accumulation of “senescent cells.” These are cells that have stopped dividing but remain active, often releasing harmful substances that promote inflammation and tissue damage.
A key aspect of cellular aging involves changes in how our genetic material is organized within the cell’s nucleus. Specifically, a tightly packed form of DNA called heterochromatin, which normally helps keep certain genes silent, tends to detach from the nuclear lamina, a supportive meshwork lining the inside of the cell’s nucleus. This detachment, often referred to as “epigenetic entropy,” can lead to the activation of genes that should remain inactive, contributing to the problems associated with senescent cells.
Scientists have now developed an innovative approach to address this issue. They engineered a system that uses a special type of chemistry, called bioorthogonal click chemistry, which allows specific reactions to occur within living cells without disrupting normal biological processes. This system, named BR-CARS (bioorthogonal reaction-driven chromatin architecture restoration system), is designed to selectively target and enter senescent cells.
Once inside these aging cells, the components of BR-CARS “click” together, effectively re-anchoring the detached heterochromatin back to the nuclear lamina. This re-tethering compacts the genetic material, restoring its proper structure and silencing the problematic genes that contribute to senescence.
This structural restoration has shown promising results, not only mechanically reversing cellular senescence but also demonstrating effectiveness in treating osteoarthritis in a rat model. The system is designed to be specific, preferentially infiltrating senescent cells due to their compromised nuclear barrier, which prevents it from affecting healthy cells.
This breakthrough represents a novel strategy for combating age-related diseases by directly addressing the structural changes in the cell’s nucleus that drive aging.
Source: link to paper